Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 12453 | 904 | 33.3 | 43% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 131 | 3 | HEMATOLOGY//HAEMOPHILIA//TRANSFUSION | 66936 |
| 966 | 2 | CLOPIDOGREL//PRASUGREL//TICAGRELOR | 10690 |
| 12453 | 1 | 2ND MESSENGER PHARMACOLOGY//3 FMPPOB 3333//30 MG D | 904 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | 2ND MESSENGER PHARMACOLOGY | authKW | 33777 | 0% | 100% | 1 |
| 2 | 3 FMPPOB 3333 | address | 33777 | 0% | 100% | 1 |
| 3 | 30 MG D | authKW | 33777 | 0% | 100% | 1 |
| 4 | 5 ALKYL 2 ARYL 4 PYRIDYLIMIDAZOLE | authKW | 33777 | 0% | 100% | 1 |
| 5 | 5 METHYL 4 3 PYRIDYL 2 BENZIMIDAZOLYL IMIDAZOLE | authKW | 33777 | 0% | 100% | 1 |
| 6 | ACETYLSALICYLIC ACID ASS | authKW | 33777 | 0% | 100% | 1 |
| 7 | ALTHAMS MODEL | authKW | 33777 | 0% | 100% | 1 |
| 8 | AORTOCORONARY VEIN BYPASS GRAFTS | authKW | 33777 | 0% | 100% | 1 |
| 9 | AREA FARMACEUT | address | 33777 | 0% | 100% | 1 |
| 10 | ASPIRIN CONCENTRATION | authKW | 33777 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Peripheral Vascular Diseases | 5239 | 23% | 0% | 205 |
| 2 | Hematology | 3347 | 19% | 0% | 172 |
| 3 | Pharmacology & Pharmacy | 1591 | 26% | 0% | 235 |
| 4 | Cardiac & Cardiovascular System | 1544 | 17% | 0% | 155 |
| 5 | Medicine, General & Internal | 1245 | 18% | 0% | 165 |
| 6 | Endocrinology & Metabolism | 137 | 6% | 0% | 54 |
| 7 | Medicine, Research & Experimental | 58 | 4% | 0% | 38 |
| 8 | Respiratory System | 55 | 3% | 0% | 24 |
| 9 | Toxicology | 26 | 2% | 0% | 22 |
| 10 | Critical Care Medicine | 17 | 1% | 0% | 11 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | 3 FMPPOB 3333 | 33777 | 0% | 100% | 1 |
| 2 | AREA FARMACEUT | 33777 | 0% | 100% | 1 |
| 3 | BIOREGULATORS | 33777 | 0% | 100% | 1 |
| 4 | CHARLES A DANA DA 907 330 BROOKLINE AVE | 33777 | 0% | 100% | 1 |
| 5 | CLIN LIB SERV | 33777 | 0% | 100% | 1 |
| 6 | CLIN PHYSIOL CNR CARDIOL | 33777 | 0% | 100% | 1 |
| 7 | INT STUDY INFARCT SURVIVAL | 33777 | 0% | 100% | 1 |
| 8 | MED MEDCARDIOVASC MED SECT333 CEDAR ST | 33777 | 0% | 100% | 1 |
| 9 | NON COMM DIS EPIDEMIOL | 33777 | 0% | 100% | 1 |
| 10 | PHYSIOL HAEMOSTASIS | 33777 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 24078 | 3% | 3% | 25 |
| 2 | THROMBOSIS RESEARCH | 23268 | 9% | 1% | 84 |
| 3 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 3437 | 1% | 1% | 9 |
| 4 | HAEMOSTASIS | 3288 | 1% | 1% | 11 |
| 5 | THROMBOSIS AND HAEMOSTASIS | 3010 | 3% | 0% | 30 |
| 6 | ATHEROSCLEROSIS REVIEWS | 2811 | 0% | 4% | 2 |
| 7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2076 | 2% | 0% | 21 |
| 8 | CLINICS IN HAEMATOLOGY | 2024 | 0% | 2% | 4 |
| 9 | SCANDINAVIAN JOURNAL OF HAEMATOLOGY | 1923 | 1% | 1% | 8 |
| 10 | ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY | 1875 | 0% | 6% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | STEIN, PD , SCHUNEMANN, H , DALEN, JE , GUTTERMAN, D , (2004) ANTITHROMBOTIC THERAPY IN PATIENTS WITH SAPHENOUS VEIN AND INTERNAL MAMMARY ARTERY BYPASS GRAFTS.CHEST. VOL. 126. ISSUE 3. P. 600S-608S | 30 | 75% | 39 |
| 2 | LIM, E , ALI, Z , ALI, A , ROUTLEDGE, T , EDMONDS, L , ALTMAN, DG , LARGE, S , (2003) INDIRECT COMPARISON META-ANALYSIS OF ASPIRIN THERAPY AFTER CORONARY SURGERY.BRITISH MEDICAL JOURNAL. VOL. 327. ISSUE 7427. P. 1309-1311 | 32 | 70% | 37 |
| 3 | STEIN, PD , DALEN, JE , GOLDMAN, S , THEROUX, P , (2001) ANTITHROMBOTIC THERAPY IN PATIENTS WITH SAPHENOUS VEIN AND INTERNAL MAMMARY ARTERY BYPASS GRAFTS.CHEST. VOL. 119. ISSUE 1. P. 278S -282S | 29 | 76% | 23 |
| 4 | STEIN, PD , DALEN, JE , GOLDMAN, S , THEROUX, P , (1998) ANTITHROMBOTIC THERAPY IN PATIENTS WITH SAPHENOUS VEIN AND INTERNAL MAMMARY ARTERY BYPASS GRAFTS.CHEST. VOL. 114. ISSUE 5. P. 658S -665S | 28 | 74% | 10 |
| 5 | STEIN, PD , DALEN, JE , GOLDMAN, S , SCHWARTZ, L , THEROUX, P , TURPIE, AGG , (1995) ANTITHROMBOTIC THERAPY IN PATIENTS WITH SAPHENOUS-VEIN AND INTERNAL MAMMARY ARTERY BYPASS GRAFTS.CHEST. VOL. 108. ISSUE 4. P. S424-S430 | 24 | 92% | 12 |
| 6 | HOFFMAN, W , FORSTER, W , (1991) 2 YEAR COTTBUS REINFARCTION STUDY WITH 30 MG ASPIRIN PER DAY.PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. VOL. 44. ISSUE 3. P. 159-169 | 28 | 74% | 18 |
| 7 | (1994) COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .2. MAINTENANCE OF VASCULAR GRAFT OR ARTERIAL PATENCY BY ANTIPLATELET THERAPY.BRITISH MEDICAL JOURNAL. VOL. 308. ISSUE 6922. P. 159-168 | 29 | 57% | 0 |
| 8 | BOCHNER, F , LLOYD, J , (1986) IS THERE AN OPTIMAL DOSE AND FORMULATION OF ASPIRIN TO PREVENT ARTERIAL THROMBOEMBOLISM IN MAN.CLINICAL SCIENCE. VOL. 71. ISSUE 6. P. 625-631 | 31 | 76% | 25 |
| 9 | VANDERMEER, J , HILLEGE, HL , KOOTSTRA, GJ , ASCOOP, CAPL , PFISTERER, M , VANGILST, WH , LIE, KI , (1993) PREVENTION OF ONE-YEAR VEIN-GRAFT OCCLUSION AFTER AORTOCORONARY-BYPASS SURGERY - A COMPARISON OF LOW-DOSE ASPIRIN, LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE, AND ORAL ANTICOAGULANTS.LANCET. VOL. 342. ISSUE 8866. P. 257-264 | 18 | 82% | 78 |
| 10 | JOHNSON, WD , KAYSER, KL , HARTZ, AJ , SAEDI, SF , (1992) ASPIRIN USE AND SURVIVAL AFTER CORONARY-BYPASS SURGERY.AMERICAN HEART JOURNAL. VOL. 123. ISSUE 3. P. 603-608 | 20 | 83% | 17 |
Classes with closest relation at Level 1 |